{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T18:01:14Z","timestamp":1771956074302,"version":"3.50.1"},"reference-count":94,"publisher":"American Chemical Society (ACS)","issue":"11","license":[{"start":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T00:00:00Z","timestamp":1634688000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-001"},{"start":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T00:00:00Z","timestamp":1634688000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-009"},{"start":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T00:00:00Z","timestamp":1634688000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology , Ministry of Science and Technology","doi-asserted-by":"publisher","award":["BT\/RLF\/Re-entry\/10\/2017"],"award-info":[{"award-number":["BT\/RLF\/Re-entry\/10\/2017"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Arkansas IDeA Network of Biomedical Research Excellence","award":["316511-356103-190"],"award-info":[{"award-number":["316511-356103-190"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Chem. Inf. Model."],"published-print":{"date-parts":[[2021,11,22]]},"DOI":"10.1021\/acs.jcim.1c00524","type":"journal-article","created":{"date-parts":[[2021,10,21]],"date-time":"2021-10-21T01:07:34Z","timestamp":1634778454000},"page":"5469-5483","source":"Crossref","is-referenced-by-count":34,"title":["Drug Repurposing to Identify Nilotinib as a Potential SARS-CoV-2 Main Protease Inhibitor: Insights from a Computational and <i>In Vitro<\/i> Study"],"prefix":"10.1021","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7811-2577","authenticated-orcid":true,"given":"Souvik","family":"Banerjee","sequence":"first","affiliation":[{"name":"Department of Physical Sciences, University of Arkansas Fort Smith, 5210 Grand Avenue, Fort Smith, Arkansas 72904, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shalini","family":"Yadav","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Shiv Nadar University, Gautam Buddha Nagar, Uttar Pradesh 201314, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sourav","family":"Banerjee","sequence":"additional","affiliation":[{"name":"Department of Chemistry, School of Basic and Applied Sciences, Adamas University, Kolkata 700126, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayo O.","family":"Fakayode","sequence":"additional","affiliation":[{"name":"Department of Physical Sciences, University of Arkansas Fort Smith, 5210 Grand Avenue, Fort Smith, Arkansas 72904, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jyothi","family":"Parvathareddy","sequence":"additional","affiliation":[{"name":"Regional Biocontainment Laboratory, University of Tennessee Health Science Center, 901 Monroe Avenue, Memphis, Tennessee 38163, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter","family":"Reichard","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Immunology, and Biochemistry, University of Tennessee Health Science Center, Memphis, Tennessee 38163, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Surekha","family":"Surendranathan","sequence":"additional","affiliation":[{"name":"Regional Biocontainment Laboratory, University of Tennessee Health Science Center, 901 Monroe Avenue, Memphis, Tennessee 38163, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Foyez","family":"Mahmud","sequence":"additional","affiliation":[{"name":"Department of Bioengineering, Rice University, 6100 Main Street, Houston, Texas 77005, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan","family":"Whatcott","sequence":"additional","affiliation":[{"name":"Department of Physical Sciences, University of Arkansas Fort Smith, 5210 Grand Avenue, Fort Smith, Arkansas 72904, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua","family":"Thammathong","sequence":"additional","affiliation":[{"name":"Department of Physical Sciences, University of Arkansas Fort Smith, 5210 Grand Avenue, Fort Smith, Arkansas 72904, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3923-3648","authenticated-orcid":true,"given":"Bernd","family":"Meibohm","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, College of Pharmacy, University of Tennessee Health Science Center, Memphis, Tennessee 38163, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6093-0985","authenticated-orcid":true,"given":"Duane D.","family":"Miller","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, College of Pharmacy, University of Tennessee Health Science Center, Memphis, Tennessee 38163, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2640-7672","authenticated-orcid":true,"given":"Colleen B.","family":"Jonsson","sequence":"additional","affiliation":[{"name":"Regional Biocontainment Laboratory, University of Tennessee Health Science Center, 901 Monroe Avenue, Memphis, Tennessee 38163, United States"},{"name":"Department of Microbiology, Immunology, and Biochemistry, University of Tennessee Health Science Center, Memphis, Tennessee 38163, United States"},{"name":"Department of Pharmaceutical Sciences, College of Pharmacy, University of Tennessee Health Science Center, Memphis, Tennessee 38163, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8865-7602","authenticated-orcid":true,"given":"Kshatresh Dutta","family":"Dubey","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Shiv Nadar University, Gautam Buddha Nagar, Uttar Pradesh 201314, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"316","published-online":{"date-parts":[[2021,10,20]]},"reference":[{"key":"ref1\/cit1","doi-asserted-by":"publisher","DOI":"10.1007\/s12038-020-00067-w"},{"key":"ref2\/cit2","unstructured":"Covid-19 Coronavirus Pandemic; WorldOmeter, 2021. Aug 15, 2021."},{"key":"ref3\/cit3","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-020-0695-z"},{"key":"ref4\/cit4","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jcim.0c00575"},{"key":"ref5\/cit5","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.0c00606"},{"key":"ref6\/cit6","doi-asserted-by":"publisher","DOI":"10.3390\/v11010060"},{"key":"ref7\/cit7","doi-asserted-by":"publisher","DOI":"10.1038\/s41401-020-0485-4"},{"key":"ref8\/cit8","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110559"},{"key":"ref9\/cit9","doi-asserted-by":"crossref","unstructured":"Zhang, L.; Jackson, C. B.; Mou, H.; Ojha, A.; Rangarajan, E. S.; Izard, T.; Farzan, M.; Choe, H. The D614G mutation in the SARS-CoV-2 spike protein reduces S1 shedding and increases infectivity, 2020. bioRxiv:10.1101\/2020.06.12.148726.","DOI":"10.1101\/2020.06.12.148726"},{"key":"ref10\/cit10","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2003138117"},{"key":"ref11\/cit11","doi-asserted-by":"publisher","DOI":"10.4155\/fmc-2020-0147"},{"key":"ref12\/cit12","unstructured":"Center for Disease\nControl\nand Prevention. Information\nfor Clinicians on Investigational Therapeutics for Patients with COVID-19, 2020. https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/hcp\/therapeutic-options.html (accessed Dec 4, 2020)."},{"key":"ref13\/cit13","unstructured":"Mayo Clinic. Coronavirus Disease 2019 (COVID-19), 2020. https:\/\/www.mayoclinic.org\/diseases-conditions\/coronavirus\/diagnosis-treatment\/drc-20479976 (accessed Jan 2, 2021)."},{"key":"ref14\/cit14","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jcim.0c00821"},{"key":"ref15\/cit15","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jcim.0c00546"},{"key":"ref16\/cit16","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jcim.0c00491"},{"key":"ref17\/cit17","doi-asserted-by":"publisher","DOI":"10.1038\/nrd1468"},{"key":"ref18\/cit18","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2018.168"},{"key":"ref19\/cit19","doi-asserted-by":"publisher","DOI":"10.1038\/d41591-020-00019-9"},{"key":"ref20\/cit20","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.01196"},{"key":"ref21\/cit21","doi-asserted-by":"publisher","DOI":"10.1016\/s2214-109x(20)30114-5"},{"key":"ref22\/cit22","doi-asserted-by":"publisher","DOI":"10.1056\/nejme2005477"},{"key":"ref23\/cit23","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2001282"},{"key":"ref24\/cit24","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2020.1752802"},{"key":"ref25\/cit25","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2020.1767691"},{"key":"ref26\/cit26","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2020.1779819"},{"key":"ref27\/cit27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13940-6"},{"key":"ref28\/cit28","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.16337"},{"key":"ref29\/cit29","unstructured":"Dorward, J.; Gbinigie, K. Lopinavir\/ritonavir: A Rapid Review of Effectiveness in COVID-19; University of Oxford: CEBM, 2020. https:\/\/www.cebm.net\/covid-19\/lopinavir-ritonavir-a-rapid-review-of-the-evidence-for-effectiveness-in-treating-covid\/ (accessed Jan 2, 2021)."},{"key":"ref30\/cit30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.106080"},{"key":"ref31\/cit31","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2020.1758791"},{"key":"ref32\/cit32","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2020.1772885"},{"key":"ref33\/cit33","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2020.1751300"},{"key":"ref34\/cit34","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2020.1761882"},{"key":"ref35\/cit35","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jcim.0c00326"},{"key":"ref36\/cit36","doi-asserted-by":"publisher","DOI":"10.1007\/3-540-26765-4_3"},{"key":"ref37\/cit37","doi-asserted-by":"publisher","DOI":"10.1126\/science.abb3405"},{"key":"ref38\/cit38","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2223-y"},{"key":"ref39\/cit39","volume-title":"PanDDA Analysis Group Deposition\u2500Crystal Structure of SARS-CoV-2 Main Protease in Complex with Z18197050","author":"Fearon D.","year":"2020"},{"key":"ref40\/cit40","volume-title":"PanDDA Analysis Group Deposition\u2500Crystal Structure of COVID-19 Main Protease in Complex with Z45617795","author":"Fearon D.","year":"2020"},{"key":"ref41\/cit41","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2020.1753577"},{"key":"ref42\/cit42","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2020.1757510"},{"key":"ref43\/cit43","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2020.1760137"},{"key":"ref44\/cit44","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2020.1760136"},{"key":"ref45\/cit45","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2020.1771424"},{"key":"ref46\/cit46","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2020.1772112"},{"key":"ref47\/cit47","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-06131-0"},{"key":"ref48\/cit48","doi-asserted-by":"publisher","DOI":"10.1021\/jm4004285"},{"key":"ref49\/cit49","doi-asserted-by":"publisher","DOI":"10.1007\/s11030-013-9477-3"},{"key":"ref50\/cit50","volume-title":"Biomolecular Simulation: GROMOS 96 Manual and User Guide","author":"Gunsteren W. F. V.","year":"1996"},{"key":"ref51\/cit51","doi-asserted-by":"publisher","DOI":"10.1021\/ci980426l"},{"key":"ref52\/cit52","doi-asserted-by":"publisher","DOI":"10.1002\/cem.1180040607"},{"key":"ref53\/cit53","doi-asserted-by":"publisher","DOI":"10.1021\/acsptsci.0c00131"},{"key":"ref54\/cit54","doi-asserted-by":"publisher","DOI":"10.1007\/s12539-013-0157-x"},{"key":"ref55\/cit55","unstructured":"Luu, T. Pharmacophore-guided Virtual Screening for Drug Repurposing; BioVia Blog, 2020. https:\/\/blogs.3ds.com\/biovia\/pharmacophore-guided-virtual-screening-for-drug-repurposing\/ (accessed Jan 2, 2021)."},{"key":"ref56\/cit56","doi-asserted-by":"publisher","DOI":"10.1126\/science.abb4489"},{"key":"ref57\/cit57","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18096-2"},{"key":"ref58\/cit58","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.0c01063"},{"key":"ref59\/cit59","unstructured":"Newswire, C. P. BerGenBio Announces Positive Interim Clinical and Translational Data from Phase II Trial of Bemcentinib in Combination with Keytruda in Checkpoint Inhibitor Refractory NSCLC Patients, 2020. https:\/\/www.prnewswire.com\/news-releases\/bergenbio-announces-positive-interim-clinical-and-translational-data-from-phase-ii-trial-of-bemcentinib-in-combination-with-keytruda-in-checkpoint-inhibitor-refractory-nsclc-patients-301083900.html (accessed Jan 2, 2021)."},{"key":"ref60\/cit60","unstructured":"Targeted Oncology. Bemcentinib Plus Pembrolizumab Combination Holds\nPromise in Clinical Trial of NSCLC; Ternyila, D., Ed. 2020. https:\/\/www.targetedonc.com\/view\/bemcentinib-plus-pembrolizumab-combination-holds-promise-in-clinical-trial-of-nsclc (accessed Jan 2, 2021)."},{"key":"ref61\/cit61","unstructured":"Medicine, USNL. Bemcentinib (BGB324) in Combination With Pembrolizumab\nin Patients With TNBC, 2019. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03184558 (accessed Jan 2, 2021)."},{"key":"ref62\/cit62","doi-asserted-by":"crossref","unstructured":"Stewart, C. A.; Gay, C. M.; Ramkumar, K.; Cargill, K. R.; Cardnell, R. J.; Nilsson, M. B.; Heeke, S.; Park, E. M.; Kundu, S. T.; Diao, L.; Wang, Q.; Shen, L.; Xi, Y.; Maria Della Corte, C.; Fan, Y.; Kundu, K.; Pickering, C. R.; Johnson, F. M.; Zhang, J.; Kadara, H.; Minna, J. D.; Gibbons, D. L.; Wang, J.; Heymach, J. V.; Byers, L. A. SARS-CoV-2 infection induces EMT-like molecular changes, including ZEB1-mediated repression of the viral receptor ACE2, in lung cancer models, 2020. bioRxiv:10.1101\/2020.05.28.122291.","DOI":"10.1016\/j.annonc.2020.08.1799"},{"key":"ref63\/cit63","doi-asserted-by":"publisher","DOI":"10.3390\/v12050525"},{"key":"ref64\/cit64","doi-asserted-by":"publisher","DOI":"10.2147\/ce.s6003"},{"key":"ref65\/cit65","unstructured":"U.S.\nFood and Drug Administration. FDA Updates the Label of Tasigna\nto Reflect that Certain Patients with a Type of Leukemia May Be Eligible\nto Stop Treatment after Sustained Response, 2017. https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-updates-label-tasigna-reflect-certain-patients-type-leukemia-may-be-eligible-stop-treatment (accessed Jan 2, 2017)."},{"key":"ref66\/cit66","unstructured":"ThePharmaLetter. Abbott Withdraws Temafloxacin, 1992. https:\/\/www.thepharmaletter.com\/article\/abbott-withdraws-temafloxacin (accessed Jan 2, 2021)."},{"key":"ref67\/cit67","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-04-779405"},{"key":"ref68\/cit68","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00307-11"},{"key":"ref69\/cit69","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.9b00654"},{"key":"ref70\/cit70","doi-asserted-by":"crossref","unstructured":"Chen, H.; Zhang, Z.; Wang, L.; Huang, Z.; Gong, F.; Li, X.; Chen, Y.; WU, J. J. First Clinical Study Using HCV Protease Inhibitor Danoprevir to Treat Naive and Experienced COVID-19 Patients, 2020. medRxiv:2020.03.22.20034041.","DOI":"10.1101\/2020.03.22.20034041"},{"key":"ref71\/cit71","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-08-797886"},{"key":"ref72\/cit72","unstructured":"Karyopharm Therapeutics. Oral Selinexor, 2020. https:\/\/www.karyopharm.com\/pipeline\/oral-selinexor\/ (accessed Jan 2, 2021)."},{"key":"ref73\/cit73","unstructured":"U.S. Food and Drug Administration. FDA grants accelerated approval to\nselinexor for multiple myeloma, 2019. https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-grants-accelerated-approval-selinexor-multiple-myeloma (accessed Jan 2, 2021)."},{"key":"ref74\/cit74","unstructured":"U.S. Food and Drug Administration. FDA approves selinexor for relapsed\/refractory\ndiffuse large B-cell lymphoma, 2020. https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-approves-selinexor-relapsedrefractory-diffuse-large-b-cell-lymphoma (accessed Jan 2, 2021)."},{"key":"ref75\/cit75","unstructured":"Norton Healthcare. Norton Healthcare physicians first in world to test\ncancer drug as COVID-19 treatment, 2020. https:\/\/nortonhealthcare.com\/news\/selinexor-covid-19-trial\/ (accessed Jan 2, 2021)."},{"key":"ref76\/cit76","unstructured":"U.S. Food and Drug Administration. Defitelio (defibrotide sodium), 2016. https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/defitelio-defibrotide-sodium (accessed Jan 2, 2021)."},{"key":"ref77\/cit77","unstructured":"Medicine, USNL. Defibrotide as Prevention and Treatment of Respiratory\nDistress and Cytokine Release Syndrome of Covid 19. (DEFACOVID), 2020. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04348383 (accessed Jan 2, 2021)."},{"key":"ref78\/cit78","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i45.16868"},{"key":"ref79\/cit79","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00754-20"},{"key":"ref80\/cit80","doi-asserted-by":"crossref","unstructured":"Mahapatra, S.; Nath, P.; Chatterjee, M.; Das, N.; Kalita, D.; Roy, P.; Satapathi, S. Repurposing Therapeutics for COVID-19: Rapid Prediction of Commercially available drugs through Machine Learning and Docking, 2020. medRxiv:2020.04.05.20054254.","DOI":"10.1101\/2020.04.05.20054254"},{"key":"ref81\/cit81","doi-asserted-by":"publisher","DOI":"10.1039\/d0ra01899f"},{"key":"ref82\/cit82","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmaid.2020.101646"},{"key":"ref83\/cit83","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2020.109883"},{"key":"ref84\/cit84","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2020.110046"},{"key":"ref85\/cit85","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-020-01539-z"},{"key":"ref86\/cit86","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2020.108216"},{"key":"ref87\/cit87","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.00836"},{"key":"ref88\/cit88","doi-asserted-by":"publisher","DOI":"10.1016\/j.yjmcc.2020.05.007"},{"key":"ref89\/cit89","doi-asserted-by":"publisher","DOI":"10.1186\/s40360-018-0270-x"},{"key":"ref90\/cit90","doi-asserted-by":"publisher","DOI":"10.1111\/bcpt.13537"},{"key":"ref91\/cit91","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2013.02.012"},{"key":"ref92\/cit92","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2021.622898"},{"key":"ref93\/cit93","doi-asserted-by":"publisher","DOI":"10.1039\/d0sc04641h"},{"key":"ref94\/cit94","doi-asserted-by":"publisher","DOI":"10.1007\/s11224-020-01605-w"}],"container-title":["Journal of Chemical Information and Modeling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.jcim.1c00524","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T17:48:16Z","timestamp":1682617696000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/doi\/10.1021\/acs.jcim.1c00524"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,20]]},"references-count":94,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11,22]]}},"alternative-id":["10.1021\/acs.jcim.1c00524"],"URL":"https:\/\/doi.org\/10.1021\/acs.jcim.1c00524","relation":{},"ISSN":["1549-9596","1549-960X"],"issn-type":[{"value":"1549-9596","type":"print"},{"value":"1549-960X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,20]]}}}